Omnicell, Inc.
Omnicell, Inc. Fundamental Analysis
Omnicell, Inc. (OMCL) shows weak financial fundamentals with a PE ratio of 881.53, profit margin of 0.17%, and ROE of 0.17%. The company generates $1.2B in annual revenue with weak year-over-year growth of -3.04%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 25.4/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze OMCL's fundamental strength across five key dimensions:
Efficiency Score
WeakOMCL struggles to generate sufficient returns from assets.
Valuation Score
ModerateOMCL shows balanced valuation metrics.
Growth Score
WeakOMCL faces weak or negative growth trends.
Financial Health Score
ExcellentOMCL maintains a strong and stable balance sheet.
Profitability Score
ModerateOMCL maintains healthy but balanced margins.
Key Financial Metrics
Is OMCL Expensive or Cheap?
P/E Ratio
OMCL trades at 881.53 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, OMCL's PEG of -9.84 indicates potential undervaluation.
Price to Book
The market values Omnicell, Inc. at 1.47 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 20.01 times EBITDA. This signals the market has high growth expectations.
How Well Does OMCL Make Money?
Net Profit Margin
For every $100 in sales, Omnicell, Inc. keeps $0.17 as profit after all expenses.
Operating Margin
Core operations generate 0.44 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $0.17 in profit for every $100 of shareholder equity.
ROA
Omnicell, Inc. generates $0.10 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Omnicell, Inc. produces operating cash flow of $130.06M, showing steady but balanced cash generation.
Free Cash Flow
Omnicell, Inc. produces free cash flow of $86.29M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $1.88 in free cash annually.
FCF Yield
OMCL converts 4.57% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
881.53
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-9.84
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.47
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.56
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.18
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.43
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.002
vs 25 benchmark
ROA
Return on assets percentage
0.001
vs 25 benchmark
ROCE
Return on capital employed
0.003
vs 25 benchmark
How OMCL Stacks Against Its Sector Peers
| Metric | OMCL Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 881.53 | 29.43 | Worse (Expensive) |
| ROE | 0.17% | 800.00% | Weak |
| Net Margin | 0.17% | -20145.00% (disorted) | Weak |
| Debt/Equity | 0.18 | 0.30 | Strong (Low Leverage) |
| Current Ratio | 1.43 | 4.64 | Neutral |
| ROA | 0.10% | -17936.00% (disorted) | Weak |
OMCL outperforms its industry in 1 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Omnicell, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
11.65%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
-81.60%
Industry Style: Defensive, Growth, Innovation
DecliningFCF CAGR
16.57%
Industry Style: Defensive, Growth, Innovation
High Growth